WebAURYXIA is a unique formulation of ferric citrate coordination complexes indicated for the control of serum phosphorus levels in adults with CKD receiving dialysis. 1,2,5 AURYXIA … WebAURYXIA is a prescription medicine that can lower the amount of phosphate in the blood for adults with chronic kidney disease (CKD) who ARE on dialysis For adults who have iron deficiency anemia, as well as CKD, and are NOT on dialysis, AURYXIA is a prescription medicine that can increase hemoglobin levels and increase iron levels in the body
Commercial/Healthcare Exchange PA Criteria - ConnectiCare
WebFeb 19, 2015 · Auryxia will seek to take patients from Sanofi's ( SNY) Renvela, which is the most commonly prescribed phosphate binder for chronic CKD patients on dialysis, with estimated U.S. sales of over... WebAURYXIA is an iron-based phosphate binder tablet that doesn’t require chewing. In a clinical study, AURYXIA helped people lower their phosphorus levels toward the normal … can college gymnasts go to the olympics
About AURYXIA AURYXIA® (ferric citrate) tablets For HCPs
WebJul 19, 2024 · Auryxia (ferric citrate) is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. What Are Side Effects of Auryxia? Common side effects of Auryxia include: diarrhea, nausea, constipation, vomiting, cough, and dark stools (related to the iron content). Webwith Auryxia for up to 28 days in three short-term trials. Across these trials, 557 unique patients were treated with Auryxia; dosage regimens in these trials ranged from 210 mg … WebApr 22, 2024 · Auryxia contains iron that binds to the phosphates you take in through food, which helps your body absorb fewer phosphates. This can lower the amount of phosphorus (a mineral) in your blood. Auryxia is used to control phosphorus levels in adults with chronic kidney disease who are on dialysis. fishman les paul pickups